Economic Times of India: Report Suggests that Indian Biosimilars Market May Reach $40 Billion USD by 2030

Published date20 October 2016
Law FirmGoodwin
Subject MatterBiotechnology,Biosimilars,India,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT